359 related articles for article (PubMed ID: 24068553)
1. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.
Gebert LF; Rebhan MA; Crivelli SE; Denzler R; Stoffel M; Hall J
Nucleic Acids Res; 2014 Jan; 42(1):609-21. PubMed ID: 24068553
[TBL] [Abstract][Full Text] [Related]
2. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex.
Kawahara Y; Zinshteyn B; Chendrimada TP; Shiekhattar R; Nishikura K
EMBO Rep; 2007 Aug; 8(8):763-9. PubMed ID: 17599088
[TBL] [Abstract][Full Text] [Related]
3. Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis.
Chaulk SG; Thede GL; Kent OA; Xu Z; Gesner EM; Veldhoen RA; Khanna SK; Goping IS; MacMillan AM; Mendell JT; Young HS; Fahlman RP; Glover JN
RNA Biol; 2011; 8(6):1105-14. PubMed ID: 21955497
[TBL] [Abstract][Full Text] [Related]
4. Loop nucleotides control primary and mature miRNA function in target recognition and repression.
Yue SB; Trujillo RD; Tang Y; O'Gorman WE; Chen CZ
RNA Biol; 2011; 8(6):1115-23. PubMed ID: 22142974
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA.
Duan R; Pak C; Jin P
Hum Mol Genet; 2007 May; 16(9):1124-31. PubMed ID: 17400653
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA miR-92a-1 biogenesis and mRNA targeting is modulated by a tertiary contact within the miR-17~92 microRNA cluster.
Chaulk SG; Xu Z; Glover MJ; Fahlman RP
Nucleic Acids Res; 2014 Apr; 42(8):5234-44. PubMed ID: 24520115
[TBL] [Abstract][Full Text] [Related]
7. Tertiary structure mapping of the pri-miRNA miR-17~92.
Chaulk SG; Fahlman RP
Methods Mol Biol; 2014; 1182():43-55. PubMed ID: 25055900
[TBL] [Abstract][Full Text] [Related]
8. Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma.
van der Ree MH; van der Meer AJ; van Nuenen AC; de Bruijne J; Ottosen S; Janssen HL; Kootstra NA; Reesink HW
Aliment Pharmacol Ther; 2016 Jan; 43(1):102-13. PubMed ID: 26503793
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-targeting therapeutics for hepatitis C.
Baek J; Kang S; Min H
Arch Pharm Res; 2014 Mar; 37(3):299-305. PubMed ID: 24385319
[TBL] [Abstract][Full Text] [Related]
10. The nuclear RNase III Drosha initiates microRNA processing.
Lee Y; Ahn C; Han J; Choi H; Kim J; Yim J; Lee J; Provost P; Rådmark O; Kim S; Kim VN
Nature; 2003 Sep; 425(6956):415-9. PubMed ID: 14508493
[TBL] [Abstract][Full Text] [Related]
11. A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis.
Treiber T; Treiber N; Plessmann U; Harlander S; Daiß JL; Eichner N; Lehmann G; Schall K; Urlaub H; Meister G
Mol Cell; 2017 Apr; 66(2):270-284.e13. PubMed ID: 28431233
[TBL] [Abstract][Full Text] [Related]
12. In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.
Ottosen S; Parsley TB; Yang L; Zeh K; van Doorn LJ; van der Veer E; Raney AK; Hodges MR; Patick AK
Antimicrob Agents Chemother; 2015 Jan; 59(1):599-608. PubMed ID: 25385103
[TBL] [Abstract][Full Text] [Related]
13. Inducing Hepatitis C Virus Resistance After Pig Liver Transplantation-A Proof of Concept of Liver Graft Modification Using Warm Ex Vivo Perfusion.
Goldaracena N; Spetzler VN; Echeverri J; Kaths JM; Cherepanov V; Persson R; Hodges MR; Janssen HL; Selzner N; Grant DR; Feld JJ; Selzner M
Am J Transplant; 2017 Apr; 17(4):970-978. PubMed ID: 27805315
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients.
van der Ree MH; van der Meer AJ; de Bruijne J; Maan R; van Vliet A; Welzel TM; Zeuzem S; Lawitz EJ; Rodriguez-Torres M; Kupcova V; Wiercinska-Drapalo A; Hodges MR; Janssen HL; Reesink HW
Antiviral Res; 2014 Nov; 111():53-9. PubMed ID: 25218783
[TBL] [Abstract][Full Text] [Related]
16. The kinase ABL phosphorylates the microprocessor subunit DGCR8 to stimulate primary microRNA processing in response to DNA damage.
Tu CC; Zhong Y; Nguyen L; Tsai A; Sridevi P; Tarn WY; Wang JY
Sci Signal; 2015 Jun; 8(383):ra64. PubMed ID: 26126715
[TBL] [Abstract][Full Text] [Related]
17. Treatment of HCV infection by targeting microRNA.
Janssen HL; Reesink HW; Lawitz EJ; Zeuzem S; Rodriguez-Torres M; Patel K; van der Meer AJ; Patick AK; Chen A; Zhou Y; Persson R; King BD; Kauppinen S; Levin AA; Hodges MR
N Engl J Med; 2013 May; 368(18):1685-94. PubMed ID: 23534542
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis.
Kim YK; Kim B; Kim VN
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1881-9. PubMed ID: 26976605
[TBL] [Abstract][Full Text] [Related]
19. The role of the precursor structure in the biogenesis of microRNA.
Starega-Roslan J; Koscianska E; Kozlowski P; Krzyzosiak WJ
Cell Mol Life Sci; 2011 Sep; 68(17):2859-71. PubMed ID: 21607569
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in human pre-miRNAs.
Iwai N; Naraba H
Biochem Biophys Res Commun; 2005 Jun; 331(4):1439-44. PubMed ID: 15883035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
